Searched for
NOVAVAX VACCINE
Novavax's protein-based jab offers better immunity against new variants: CEO Stanley ErckNovavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.- Two large phase-3 trials of Novavax's COVID-19 vaccine show high levels of protection against infection: Research headSII and Novavax are the key partners in the development and manufacturing of the Novavax vaccine, marketed by Novavax as Nuvaxovid and by S...
- US envoy, Novovax CEO hail role played by India and SII during COVID-19 pandemicThe delegates noted the critical role played by US-India cooperation in addressing the COVID-19 pandemic and other global health challenges...
- FDA flags heart issues after taking Novavax vaccineIn the company's nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis, a t...
- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- Serum Institute could export 20-30 million vaccine doses a month to COVAX: Adar PoonawallaAdar Poonawalla said the company's production of the vaccine could go up to 240 million doses a month from around 220 million now.
- Novavax and the recombinant protein vaccine: What you need to knowThe recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in...
- SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
- Novavax vaccine 90% effective in US trial, all you need to know about this COVID fighterNovavax Inc on June 14 said its COVID-19 vaccine was more than 90% effective, including against a variety of concerning variants of the cor...
- Novavax set for India launch with Serum Institute as manufacturing partnerThe large Novavax trials conducted on 29,960 persons in the US and Mexico have delivered results that equal the Pfizer and Moderna jabs and...
- Novavax: Large study finds COVID-19 shot about 90% effectiveWhile demand for COVID-19 shots in the US has dropped off dramatically, the need for more vaccines around the world remains critical. The N...
- Serum Institute wants to manufacture Russian Covid vaccine Sputnik V in India, seeks DCGI nodThe SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also ...
- Will meet vaccine delivery goals by second half of 2021: NovavaxSerum Institute, which has signed up to manufacture upto 1 billion doses of Novavax's vaccine, is expected to file for approval in India in...
- Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
- India takes up with US ban on exports of Covid-19 vaccine raw materialsLast week, Serum Institute of India (SII) CEO Adar Poonawalla had rued that the production of Covid-19 vaccines and global availability cou...
- Novavax hopes ease of storage, pricing will give its vax edgeThe company, which transferred its vaccine technology to Serum Institute of India for distribution in India and middle-income countries, is...
- India sends first vaccine doses to Africa under WHO's COVAX programme"Fulfilling our commitment to help the world with COVID-19 vaccines, supplies of Made-in-India vaccine commence today for Africa under COVA...
- India's Serum Institute seeks approval to conduct local trial for Novavax COVID-19 vaccineNovavax's UK trial, which enrolled 15,000 people aged 18 to 84, is expected to be used to apply for use in Britain, the European Union and ...
- India's Serum Institute to stockpile Novavax vaccine candidate from around April"Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April," he said.
- Serum Institute to try out Novavax vaccine in October in partnership with ICMRThe trials of the glycoprotein subunit nanoparticle adjuvanted vaccine developed by Novavax will be led by ICMR-National AIDS Research Inst...
Load More
